We are live on ! Find out more
PIP

Peachtree Investment Partners Portfolio holdings

AUM $312M
1-Year Est. Return 27.01%
This Fund
S&P 500
This Quarter Est. Return
-11.74%
1 Year Est. Return
+27.01%
3 Year Est. Return
+92.23%
5 Year Est. Return
+139.64%
10 Year Est. Return
AUM
$160M
AUM Growth
-$57.4M
Cap. Flow
-$29.7M
Cap. Flow %
-18.56%
Top 10 Hldgs %
59.55%
Holding
109
New
8
Increased
23
Reduced
47
Closed
13

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$2.05M
2
LLY icon
Eli Lilly
LLY
+$1.98M
3
HSY icon
Hershey
HSY
+$1.23M
4
BMY icon
Bristol-Myers Squibb
BMY
+$988K
5
MRK icon
Merck
MRK
+$921K

Sector Composition

Rank Sector Weight
1 Technology 34.97%
2 Healthcare 17.15%
3 Financials 12.97%
4 Consumer Discretionary 12.51%
5 Consumer Staples 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.57T
$24.6M 15.35%
179,868
-14,487
-7% -$2.19M
MSFT icon
2
Microsoft
MSFT
$3.73T
$19.9M 12.39%
77,317
-11,887
-13% -$3.23M
V icon
3
Visa
V
$683B
$11M 6.89%
56,049
-1,612
-3% -$333K
HD icon
4
Home Depot
HD
$352B
$9.56M 5.97%
34,868
-895
-3% -$264K
ACN icon
5
Accenture
ACN
$106B
$6.62M 4.13%
23,849
-231
-1% -$69.4K
COST icon
6
Costco
COST
$419B
$6.57M 4.1%
13,715
-3,950
-22% -$2M
MA icon
7
Mastercard
MA
$496B
$4.98M 3.11%
15,798
-461
-3% -$159K
LLY icon
8
Eli Lilly
LLY
$1.05T
$4.18M 2.61%
12,907
+6,608
+105% +$1.98M
ADP icon
9
Automatic Data Processing
ADP
$108B
$4.09M 2.55%
19,468
-78
-0.4% -$17.1K
UNH icon
10
UnitedHealth
UNH
$371B
$3.93M 2.45%
7,645
-592
-7% -$297K
NOC icon
11
Northrop Grumman
NOC
$80.1B
$3.83M 2.39%
8,003
+402
+5% +$185K
SCHG icon
12
Schwab US Large-Cap Growth ETF
SCHG
$62.8B
$3.42M 2.13%
235,952
-138,476
-37% -$2.21M
ABT icon
13
Abbott
ABT
$185B
$3.31M 2.06%
30,446
-3,521
-10% -$400K
TJX icon
14
TJX Companies
TJX
$178B
$3.21M 2%
57,424
-1,612
-3% -$97.6K
MCK icon
15
McKesson
MCK
$103B
$2.97M 1.85%
9,109
+6,406
+237% +$2.05M
HSY icon
16
Hershey
HSY
$36.8B
$2.46M 1.53%
11,412
+5,646
+98% +$1.23M
JPM icon
17
JPMorgan Chase
JPM
$947B
$2.32M 1.45%
20,614
-1,841
-8% -$228K
ZTS icon
18
Zoetis
ZTS
$31.5B
$2.28M 1.42%
13,269
-6,681
-33% -$1.16M
JNJ icon
19
Johnson & Johnson
JNJ
$618B
$2.27M 1.41%
12,769
+1,109
+10% +$198K
ELV icon
20
Elevance Health
ELV
$85B
$1.96M 1.22%
4,059
+1,661
+69% +$822K
NKE icon
21
Nike
NKE
$62.2B
$1.86M 1.16%
18,195
-2,334
-11% -$276K
MCD icon
22
McDonald's
MCD
$195B
$1.77M 1.11%
7,175
+94
+1% +$23.1K
AMZN icon
23
Amazon
AMZN
$2.99T
$1.62M 1.01%
15,225
-14,255
-48% -$1.78M
BMY icon
24
Bristol-Myers Squibb
BMY
$131B
$1.55M 0.97%
20,158
+12,974
+181% +$988K
DHR icon
25
Danaher
DHR
$142B
$1.53M 0.95%
6,794
-1,656
-20% -$381K

Similar funds

Peachtree Investment Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Peachtree Investment Partners held 109 positions worth $160M, down 26% from $218M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Peachtree Investment Partners withdrew a net $29.7M in Q2 2022, closing 13 positions and reducing 47 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.91M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 35% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Peachtree Investment Partners opened a new position in Merck worth $947K.

  • Peachtree Investment Partners's largest Q2 2022 buy was Merck: 10,387 shares worth $947K.
  • Peachtree Investment Partners added most to McKesson in Q2 2022, an estimated $2.05M increase.
  • Peachtree Investment Partners's biggest Q2 2022 reduction was Vanguard S&P 500 ETF, cutting an estimated $4.91M.
  • Peachtree Investment Partners fully exited iShares Core S&P 500 ETF in Q2 2022, selling an estimated $1.91M.
  • Peachtree Investment Partners's ten largest holdings make up 60% of its $160M portfolio in Q2 2022.
  • Peachtree Investment Partners opened 8 new positions and closed 13 in Q2 2022.
  • Peachtree Investment Partners's portfolio value fell 26% quarter-over-quarter to $160M.

Based on Peachtree Investment Partners's 13F filing for Q2 2022, filed 16 Aug 2022.